PHOTODYNAMIC INACTIVATION OF STREPTOCOCCUS PNEUMONIAE: INFLUENCE OF LUNG SURFACTANT AND COMBINATION WITH ANTIBIOTICS

Vol 4, 2026 - 345891
Abstract
Favorite this paper
How to cite this paper?
Abstract

Lower respiratory tract infections (LRTIs) are a major concern for global public health and the fifth leading cause of death worldwide, accounting for approximately 2.5 million deaths annually. Pneumonia represents approximately 60% of LRTIs, and given the increasing prevalence of multidrug-resistant microorganisms, its treatment has become increasingly limited. In this context, antimicrobial photodynamic therapy (aPDT), also known as photodynamic inactivation (PDI), has emerged as a promising alternative strategy. PDI involves a photosensitizer (PS) that, upon activation by light at an appropriate wavelength, undergoes photophysical and photochemical processes that generate reactive oxygen species (ROS). These species can damage multiple cellular targets, resulting in nonspecific cellular damage and reducing the likelihood of resistance development. However, PDI efficacy can be hindered by biological barriers, such as lung surfactant (LS), which may interfere with PS–bacteria interactions. To overcome this limitation, indocyanine green (ICG) can be associated with Gantrez™ AN-139 to improve PS delivery and bacterial interaction. Therefore, this study investigated PDI against susceptible and resistant Streptococcus pneumoniae strains in the presence and absence of LS using ICG associated with Gantrez™ AN-139. After determining subinhibitory PDI doses, these parameters were employed in combination with antibiotics. The resistant strain exhibited a photoinactivation profile similar to that of the susceptible strain, while LS strongly inhibited PDI in both strains. Synergistic effects were observed regardless of the order of PDI and antibiotic administration. Successive PDI cycles resulted in fourfold and twofold reductions in the minimum inhibitory concentration (MIC) of clindamycin and amoxicillin, respectively. These findings reinforce the potential of PDI as an adjuvant strategy for pneumococcal infections and highlight the importance of optimizing combined therapies. To the best of our knowledge, this is the first study to evaluate the interaction between ICG-mediated PDI and antibiotic therapy against S. pneumoniae, providing new evidence for approaches aimed at enhancing antimicrobial efficacy against a major pathogen involved in pneumonia.

 

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Instituto de Física de São Carlos (IFSC), USP
  • 2 Department of Biomedical Engineering, Texas A&M University
Track
  • 5. Photobiology
Keywords
Photodynamic Inactivation
Pneumonia
Antimicrobial resistance
Lung surfactant
Combination therapy